M. Gatlin

发表

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

B. Pitt, F. Zannad, W. Remme, 2003 .

Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.

S. Schwartz, B. Dunning, P. Hollander, 2001, Diabetes care.

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

E. Horton, J. Foley, M. Gatlin, 2000 .

A Randomized, Double‐Blind Trial Comparing the Effects of Amlodipine Besylate/Benazepril HCl vs Amlodipine on Endothelial Function and Blood Pressure

E. Mohler, P. Ouyang, R. Vogel, 2006, Journal of clinical hypertension.

Valsartan, a New Angiotensin II Receptor Antagonist: A Double‐Blind Study Comparing the Incidence of Cough with Lisinopril and Hydrochlorothiazide

D. Henry, M. Gatlin, D. Henry, 1997, Journal of clinical pharmacology.

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

E. Horton, J. Foley, M. Gatlin, 2000, Diabetes care.

Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Ranging Study

T. Ogihara, T. Saruta, R. Bittman, 2004, Journal of clinical hypertension.

Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

B. Pitt, F. Zannad, W. Remme, 2003 .

Dose-response efficacy of valsartan, a new angiotensin II receptor blocker

J. Pool, M. Gatlin, R. Glazer, 1999, Journal of Human Hypertension.

Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours.

J. Pool, M. Weber, M. Gatlin, 1997, Clinical therapeutics.

EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

B. Pitt, F. Zannad, W. Remme, 2003 .

P-498: Blood pressure response of eplerenone according to baseline characteristics

W. White, R. Weiss, M. Weinberger, 2003 .

H29: Comparison of the efficacy of two angiotensin II antagonists, valsartan and losartan, in essential hypertension

S. Oparil, T. Hedner, M. Gatlin, 1997 .

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

G. Bakris, B. Pitt, V. Shi, 2008, The New England journal of medicine.

Efficacy of combination therapy with amlodipine besylate/benazepril hydrochloride for lowering systolic blood pressure in stage 2 hypertension.

M. Gatlin, J. Neutel, D. Purkayastha, 2006, The American journal of geriatric cardiology.

Nateglinide, but not glyburide, selectively enhances early insulin release and more effectively controls post-meal glucose excursions with less total insulin exposure

S. Schwartz, B. Dunning, M. Gatlin, 2000 .

Combination therapy with nateglinide and a thiazolidinedione improves glycemic control in type 2 diabetes.

J. Rosenstock, J. Foley, M. Gatlin, 2002, Diabetes care.

Initial combination therapy in older patients with systolic hypertension: results of the systolic evaluation of lotrel efficacy and comparative therapies (select) study

M. Gatlin, J. Neutel, David H. G. Smith, 2004 .

Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study

M. Gatlin, J. Neutel, D. Purkayastha, 2005, Journal of clinical hypertension.

Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (the LOGIC study).

M. Gatlin, O. Nwose, Wentworth G Jarrett, 2004, Current therapeutic research, clinical and experimental.

A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.

S. Oparil, T. Hedner, M. Gatlin, 1999, American journal of hypertension.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

B. Pitt, F. Zannad, W. Remme, 2003, The New England journal of medicine.